ABEONA THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ABEONA THERAPEUTICS INC. (ABEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.03 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-11-15
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-09-30 was 1.03M shares, a 200.50% increase year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-06-30 was 1.21M shares, a 36.44% decline year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-03-31 was 2.15M shares, a 82.79% increase year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 342.10K shares, a 223.96% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2021-09-30 | 1.03M shares 10-Q · filed 2021-11-15 | 2.23M shares derived: sum of 2 quarters · filed 2021-11-15 | 4.38M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 1.21M shares 10-Q · filed 2021-07-28 | 3.36M shares 10-Q · filed 2021-07-28 | |
| 2021-03-31 | 2.15M shares 10-Q · filed 2021-05-17 | ||
| 2020-09-30 | 342.10K shares 10-Q · filed 2021-11-15 | 2.24M shares derived: sum of 2 quarters · filed 2021-11-15 | 3.42M shares 10-Q · filed 2021-11-15 |
| 2020-06-30 | 1.90M shares 10-Q · filed 2021-07-28 | 3.07M shares 10-Q · filed 2021-07-28 | |
| 2020-03-31 | 1.18M shares 10-Q · filed 2021-05-17 | ||
| 2019-09-30 | 105.60K shares 10-Q · filed 2020-11-09 | 1.29M shares derived: sum of 2 quarters · filed 2020-11-09 | 1.49M shares 10-Q · filed 2020-11-09 |
| 2019-06-30 | 1.18M shares 10-Q · filed 2020-08-10 | 1.38M shares 10-Q · filed 2020-08-10 | |
| 2019-03-31 | 201.00K shares 10-Q · filed 2020-05-06 | ||
| 2018-09-30 | 157.00K shares 10-Q · filed 2019-11-12 | 1.03M shares 10-Q · filed 2019-11-12 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-15 | ||
| 2012-09-30 | 0.00 shares 10-Q · filed 2012-11-14 | 510.00K shares derived: sum of 2 quarters · filed 2012-11-14 | 510.00K shares 10-Q · filed 2012-11-14 |
| 2012-06-30 | 510.00K shares 10-Q · filed 2012-08-14 | 510.00K shares 10-Q · filed 2012-08-14 | |
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | 0.00 shares 10-Q · filed 2012-11-14 | 475.00K shares derived: sum of 2 quarters · filed 2012-11-14 | 575.00K shares 10-Q · filed 2012-11-14 |
| 2011-06-30 | 475.00K shares 10-Q · filed 2012-08-14 | 575.00K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |